|
|
|
|
Science Sparks @ ACTREC
|
 18th April 2022 |
Vol. No. 11; Issue No. 522 |
|
|
Publications
|
|
1. Guha A, Vijan A, Agarwal U, Goda JS, Mahajan A, Shetty N, Khattry N (2022). Imaging for plasma cell dyscrasias: What, when, and how? Frontiers in Oncology.
2. Chopra S, Goda J, Mittal P, Mulani J, Pant S, Pai V, Kannan S, Deodhar K, Krishnamurthy M, Menon S, Charnalia M, Shah S, Rangarajan V, Gota V, Naidu L, Sawant S, Thakkar P, Popat P, Ghosh J, Rath S, Gulia S, Engineer R, Mahantshetty U, Gupta S (2022). Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial. BMJ Open.
3. Sudharsan MG, Venkatraman P (2022). A crystal form of PSMD10 Gankyrin with channels accessible to small molecules. Current Science. 122(6): 674-681.
4. Khan MA, Siddiqui MQ, Kuligina E, Varma AK (2022). Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach. International Journal of Biological Macromolecules.
|
|
|
|
|
Interesting Reads
|
|
Toya R, Saito T, Fukugawa Y, Matsuyama T, Matsumoto T, Shiraishi S, Murakami D, Orita Y, Hirai T, Oya N. Prevalence and risk factors of retro-styloid lymph node metastasis in oropharyngeal carcinoma. Ann Med. 54(1):436-441, 2022.
|
|
|
Legends of Science
|
|
Alok Kumar Datta
Alok Kumar Datta obtained his Ph.D. from Kolkata University in 1974. He was the first to establish that the adenosine kinase of purine auxotrophic parasites could be an exploitable chemotherapeutic target. His laboratory worked on cloning the enzyme from Leishmania donovani, delineating its active site, mechanical aspects of the reaction, and structural analysis. Dr. Datta is a recipient of the Professor IS Bhatia Memorial Award of the Society of Biological Chemists. He is a Fellow of the Indian Academy of Sciences, Bangalore; National Academy of Sciences, Allahabad.
|
|
| |
|
Jayaraman Gowrishankar
Jayaraman Gowrishankar received his Ph.D. from the University of Melbourne, Australia, in 1983. His contributions include the discovery of the operon and its exquisite osmotic regulation. His group developed and patented a generic process for salt-inducible overproduction of recombinant proteins in E coli. He was the recipient of the INSA medal for young scientist in 1986; CSIR young scientist award in 1987; SS Bhatnagar Prize in 1997; Padma Shri Award in 2013. Dr. Gowrishankar is the Fellow of the Indian Academy of Sciences, Bangalore; National Academy of Sciences, Allahabad.
|
|
| |
|
|
|
|
Do You Know?
In 1943, Pap test named for its inventor, George Papanicolaou, enabled doctors to detect and treat cervical cancers or pre-cancers before they spread.
|
|
|
|
Cancer News
|
|
|
| |
|
|
| |
|
New knowledge on lymphoid cell maturity could lead to more effective IBD therapies
|
|
15 April 2022, ScienceDaily
|
|
A research group has analyzed how certain immune cells known as innate lymphoid cells (ILCs) develop into mature cells that play a part in inflammatory bowel disease (IBD). The findings could pave the way for more effective treatments against IBD, a disease that causes considerable suffering and that is linked to an increased risk of colorectal cancer...
|
|
|
| |
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
